23 May 2013
Keywords: cobra, therapeutics, awarded, key, dna, patent, usa
Article | 09 November 1999
Cobra Therapeutics, the UK gene expression company formerly known asTherexys, says it has been granted US patent 5,972,708 covering its novel ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.